KGI Asia Commentary

2023.03.31 09:00

HSI rose 116 points on Friday

The Hang Seng Index rose 116 points or 0.6% to 20,309 on Thursday. HSTECH rose 23 points or 0.6% to 4,270 and HSCEI rose 43 points or 0.6% to 6,922. Daily market turnover was HK$133.5bn.

 

Stocks close higher for second day in a row

The rebound in U.S. initial jobless claims has boosted hopes that the Fed's rate hike cycle will soon end. U.S. stocks continued to move higher on Thursday as the concern on banking crisis has further ease. The S&P 500 gained 0.57% to close at 4,050.83. The Nasdaq Composite rose 0.73% to close at 12,013.47 as investors continued to have interest in technology stocks. The Dow Jones Industrial Average rose 141.43 points, or 0.43%, to 32,859.03. The Cboe Volatility Index fell to 19 from 30 in mid-March, and back at levels last seen earlier this month. Technology stocks were among the biggest gainers overnight as U.S. Treasury yields stabilized after a rebound. Apple, Amazon and Microsoft led gains in the big tech stocks, though Alphabet fell about half a percent. Meanwhile, Alibaba extended yesterday's gains, rising more than 3%. U.S. President Joe Biden on Thursday called on regulators to tighten oversight of banks, urging regulators to reinstate tough rules on mid-sized banks in the United States.

Jobless claims rise to 198,000, more than expected

Initial claims for unemployment benefits totaled 198,000 in the week ended March 25, an increase of 7,000 from the previous week and slightly higher than the forecast of 195,000. Bigger-than-expected jobless claims added to hopes that the Federal Reserve might slow down its tightening as the labor market is cooling. Meanwhile, final gross domestic product figures released by the Commerce Department showed the economy grew at an annualized rate of 2.6% in the fourth quarter, slightly below the previous estimate of 2.7%. The change was largely due to downward revisions to consumer spending and exports.

Hong Kong Stock Connect had a net inflow of HK$0.82bn on Thursday, of which Meituan (3690) had the largest net inflow, reaching HK$1.44bn; followed by China Mobile (941). XPeng (9868) recorded the largest net outflow at HK$0.11bn, followed by Innovent Bio (1801).

Recommended Stocks
Capture the moment and trade with KGI Asia's insights
Stocks
Recommended
Stocks
Recommended

Non-IFRS profit of Tencent for last year fell 6.6% to RMB115.649bn. Revenue was RMB554.552 billion, down 1% YoY. Both in line with the market consensus. By business segment, revenue from value-added services business dropped by 1.4% YoY to RMB287.565 billion. The fourth quarter is a seasonally strong period for its international games business, which contributed 33% of the games revenue in the fourth quarter of 2022, compared to 28% in the fourth quarter of 2021. Revenue from online advertising business recorded recovery later in the year, due to the robust demand for Video Accounts in-feed ads, rapid growth of Mini Programs ads, and recovery of mobile ad network. Revenue from financial technology and corporate services business reached RMB177.064 billion, up 2.8% YoY. As consumption recovered in China, daily average commercial payment volume rebounded to a double-digit year-on-year growth rate, quarter to date, in the first quarter of 2023. Overall, the worst time was over. All segments recorded improvement, Future growth driver continue to be seen in the development of video account services and the overseas expansion of games.  Target price: $460; Stop- Loss price: $320.

Wen Kit Kenny is a SFC licensed person accredited to KGI Group to carry on regulated activities (for details, please refer to:https://apps.sfc.hk/publicregWeb/indi/AJF244/details). He and/or his associate do not have any financial interest in the recommended issuer or new listing applicant.

The materials contained herein are provided by KGI Asia Limited ("KGI") for information only. While such materials are based on or derived from sources believed to be reliable, KGI makes no representation or warranty (express or implied) as to their accuracy or reliability. Neither the information nor the opinions expressed herein constitute, or are to be construed as, an offer or invitation or solicitation of an offer to buy or sell any securities or investments. KGI and its officers, employees, agents and affiliates may have interests in the securities or investments covered herein and accept no liability whatsoever for any loss or consequence whatsoever (whether direct or indirect) resulting from any use of or reliance by you on such materials.